These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 34767673)
1. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1. Yang J; Ye J; Ma T; Tang F; Huang L; Liu Z; Tian S; Cheng X; Zhang L; Guo Z; Tu F; He M; Xu X; Lu X; Wu Y; Zeng X; Zou J; Wang X; Peng W; Zhang P Hepatology; 2022 Sep; 76(3):612-629. PubMed ID: 34767673 [TBL] [Abstract][Full Text] [Related]
2. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53. Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611 [TBL] [Abstract][Full Text] [Related]
3. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination. Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376 [TBL] [Abstract][Full Text] [Related]
4. TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells. Zhang Z; Xu C; Zhang X; Huang L; Zheng C; Chen H; Wang Y; Ju H; Yao Q Oncol Res; 2017 May; 25(5):691-699. PubMed ID: 28244856 [TBL] [Abstract][Full Text] [Related]
5. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells. Wang X; Shi W; Shi H; Lu S; Wang K; Sun C; He J; Jin W; Lv X; Zou H; Shu Y J Exp Clin Cancer Res; 2016 Jun; 35(1):100. PubMed ID: 27329103 [TBL] [Abstract][Full Text] [Related]
6. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer. Tang J; Tian Z; Liao X; Wu G Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102 [TBL] [Abstract][Full Text] [Related]
7. Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT. Wang B; Wang G; Wang Q; Zhu Z; Wang Y; Chen K; Yang H Cancer Cell Int; 2019; 19():284. PubMed ID: 31719797 [TBL] [Abstract][Full Text] [Related]
8. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma. Chen Y; Li L; Qian X; Ge Y; Xu G Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):190-196. PubMed ID: 28065743 [TBL] [Abstract][Full Text] [Related]
9. TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. Chen L; Zhu G; Johns EM; Yang X Nat Commun; 2018 Mar; 9(1):1223. PubMed ID: 29581427 [TBL] [Abstract][Full Text] [Related]
10. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex. Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907 [TBL] [Abstract][Full Text] [Related]
11. Tripartite Motif-containing Protein 11 Silencing Inhibits Proliferation and Glycolysis and Promotes Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Inactivating Signal Transduction and Activation of Transcription Factor 3/c-Myc Signaling. Xuan T J Physiol Investig; 2024 Jan; 67(1):37-46. PubMed ID: 38780271 [TBL] [Abstract][Full Text] [Related]
12. TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer. Pan Y; Yu H; Lu F Technol Cancer Res Treat; 2023; 22():15330338231178639. PubMed ID: 37248611 [TBL] [Abstract][Full Text] [Related]
13. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system. Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226 [TBL] [Abstract][Full Text] [Related]
14. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525 [TBL] [Abstract][Full Text] [Related]
15. Tripartite Motif Containing 11 Interacts with DUSP6 to Promote the Growth of Human Osteosarcoma Cells through Regulating ERK1/2 Pathway. Wang Z; Xu X; Tang W; Zhu Y; Hu J; Zhang X Biomed Res Int; 2019; 2019():9612125. PubMed ID: 31950060 [TBL] [Abstract][Full Text] [Related]
16. TRIM11, a new target of p53, facilitates the migration and invasion of nasopharyngeal carcinoma cells. Zhao Z; Deng J; Lu M; Yang J; Chen L; Li D; Sang Y Mol Biol Rep; 2023 Jan; 50(1):731-737. PubMed ID: 36376537 [TBL] [Abstract][Full Text] [Related]
17. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554 [TBL] [Abstract][Full Text] [Related]
18. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Zhang CZ J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688 [TBL] [Abstract][Full Text] [Related]
19. Tripartite motif‑containing 11 regulates the proliferation and apoptosis of breast cancer cells. Dai X; Geng F; Li M; Liu M Oncol Rep; 2019 Apr; 41(4):2567-2574. PubMed ID: 30816511 [TBL] [Abstract][Full Text] [Related]
20. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193. Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]